Trials / Completed
CompletedNCT05560243
Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil
Development, Implementation, and Evaluation of a Tobacco Cessation Intervention Tailored to Patients Living With HIV (PLWH) in Brazil: A Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall goal of this feasibility study is to make adaptations to these evidence-based approaches in collaboration with PLWH and health care providers working with this population, and develop, implement, and evaluate the feasibility and scalability of a theory-based, culturally relevant tobacco cessation intervention for PLWH receiving care through the public health system in a southern town in Brazil (Londrina). This proposal will focus on the intervention development, pretesting, and feasibility testing. The primary outcome will be a 7-day point prevalence abstinence (defined as no tobacco use in the past 7 days and verified through measurement of salivary cotinine and exhaled carbon monoxide levels) at 6-month follow-up. We will also conduct detailed treatment fidelity and scalability assessments (acceptability, feasibility, potential reach and adoption, alignment with the strategic context) to inform a full-scale efficacy trial.
Detailed description
This study aims at developing and examining feasibility and scalability of a theory-based, culturally relevant tobacco cessation intervention for PLWH receiving care through the public health system in a southern town in Brazil. It consists of three phases: formative assessments with patients and health care providers to inform relevant components of the intervention, pretesting of the intervention components, and pilot testing of the intervention (feasibility).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Tobacco cessation | Tobacco cessation program consisting of cognitive-therapy sessions and pharmacological management |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2023-08-31
- Completion
- 2023-08-31
- First posted
- 2022-09-29
- Last updated
- 2024-12-11
- Results posted
- 2024-12-11
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05560243. Inclusion in this directory is not an endorsement.